EBiSC best practice: How to ensure optimal generation, qualification, and distribution of iPSC lines

Stem Cell Reports. 2021 Aug 10;16(8):1853-1867. doi: 10.1016/j.stemcr.2021.07.009.

Abstract

Disease-relevant human induced pluripotent stem cells (iPSCs) are generated worldwide for research purposes; however, without robust and practical ethical, legal, and quality standards, there is a high risk that their true potential will not be realized. Best practices for tissue procurement, iPSC reprogramming, day-to-day cultivation, quality control, and data management aligned with an ethical and legal framework must be included into daily operations to ensure their promise is maximized. Here we discuss key learning experiences from 7 years of operating the European Bank for induced Pluripotent Stem Cells (EBiSC) and recommend how to incorporate solutions into a daily management framework.

Keywords: EBiSC; banking; biobank; data management; ethics; guidance; iPSC; legal; quality; quality control; repository; reprogramming.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biological Specimen Banks / ethics
  • Biological Specimen Banks / standards
  • Biological Specimen Banks / statistics & numerical data*
  • Cell Culture Techniques / methods
  • Cell Culture Techniques / standards
  • Cell Differentiation / genetics
  • Cell Line
  • Cellular Reprogramming / genetics*
  • Cryopreservation / methods*
  • Europe
  • Humans
  • Induced Pluripotent Stem Cells / cytology*
  • Induced Pluripotent Stem Cells / metabolism*
  • Quality Control